Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2141

1.

Prognostic Value of Quality of Life in Endocrine Therapy for Elderly Patients With Breast Cancer: A Retrospective Study.

Takada K, Kashiwagi S, Asano Y, Goto W, Takahashi K, Shibutani M, Amano R, Takashima T, Tomita S, Hirakawa K, Ohira M.

Anticancer Res. 2019 Jun;39(6):2941-2950. doi: 10.21873/anticanres.13424.

PMID:
31177133
2.

Small intestinal intussusception in an adult.

Takada K, Fujimoto N, Ozeki T, Nishimura J, Miyamoto Y, Asano M, Fuchimoto Y, Wada S, Ozaki S, Igawa T, Sonobe H, Kishimoto T.

J Clin Pathol. 2019 Jul;72(7):510. doi: 10.1136/jclinpath-2017-204973. Epub 2019 Jun 6. No abstract available.

PMID:
31171576
3.

Association between peripheral blood markers and immune-related factors on tumor cells in patients with resected primary lung adenocarcinoma.

Takada K, Shimokawa M, Tanaka K, Kohashi K, Haro A, Osoegawa A, Tagawa T, Azuma K, Okamoto I, Oda Y, Mori M.

PLoS One. 2019 Jun 4;14(6):e0217991. doi: 10.1371/journal.pone.0217991. eCollection 2019.

4.

The influence of clinical T factor on predicting pathological N factor in resected lung cancer.

Shimamatsu S, Takenoyama M, Shimokawa M, Takada K, Edagawa M, Toyozawa R, Nosaki K, Oba T, Tagawa T, Yamaguchi M, Taguchi K, Seto T.

Ann Thorac Surg. 2019 May 16. pii: S0003-4975(19)30703-9. doi: 10.1016/j.athoracsur.2019.04.026. [Epub ahead of print]

PMID:
31103386
5.

Clinical and Prognostic Significance of the Epithelial-Mesenchymal Transition in Stage IA Lung Adenocarcinoma: A Propensity Score-Matched Analysis.

Matsubara T, Tagawa T, Takada K, Toyokawa G, Shimokawa M, Kozuma Y, Akamine T, Haro A, Osoegawa A, Mori M.

Clin Lung Cancer. 2019 Apr 19. pii: S1525-7304(19)30086-5. doi: 10.1016/j.cllc.2019.04.006. [Epub ahead of print]

PMID:
31103348
6.

Successful Treatment of Hepatocellular Carcinoma with Transcatheter Arterial Chemoembolization followed by Radical Liver Transplantation in a Patient with Severe Liver Damage.

Nakamura H, Kawano Y, Miyanishi K, Ishikawa K, Kubo T, Tanaka S, Takada K, Kobune M, Harada K, Kawamura N, Shimamura T, Kanno-Okada H, Kato J.

Case Rep Oncol. 2019 Apr 3;12(1):289-296. doi: 10.1159/000499703. eCollection 2019 Jan-Apr.

7.

EPO-R+ myelodysplastic cells with ring sideroblasts produce high erythroferrone levels to reduce hepcidin expression in hepatic cells.

Miura S, Kobune M, Horiguchi H, Kikuchi S, Iyama S, Murase K, Goto A, Ikeda H, Takada K, Miyanishi K, Kato J.

Blood Cells Mol Dis. 2019 Apr 30;78:1-8. doi: 10.1016/j.bcmd.2019.04.014. [Epub ahead of print]

PMID:
31082798
8.

[Treatment of POEMS syndrome with lenalidomide and dexamethasone].

Goto A, Iyama S, Sugama Y, Yoshida M, Ibata S, Tatekoshi A, Fujita C, Kikuchi S, Ikeda H, Murase K, Takada K, Kato J, Kobune M.

Rinsho Ketsueki. 2019;60(4):308-313. doi: 10.11406/rinketsu.60.308. Japanese.

PMID:
31068561
9.

The Revised Structure of the Cyclic Octapeptide Surugamide A.

Matsuda K, Kuranaga T, Sano A, Ninomiya A, Takada K, Wakimoto T.

Chem Pharm Bull (Tokyo). 2019;67(5):476-480. doi: 10.1248/cpb.c19-00002.

10.

The association and prognostic impact of enhancer of zeste homologue 2 expression and epithelial-mesenchymal transition in resected lung adenocarcinoma.

Matsubara T, Toyokawa G, Takada K, Kinoshita F, Kozuma Y, Akamine T, Shimokawa M, Haro A, Osoegawa A, Tagawa T, Mori M.

PLoS One. 2019 May 1;14(5):e0215103. doi: 10.1371/journal.pone.0215103. eCollection 2019.

11.

A humanized MDCK cell line for the efficient isolation and propagation of human influenza viruses.

Takada K, Kawakami C, Fan S, Chiba S, Zhong G, Gu C, Shimizu K, Takasaki S, Sakai-Tagawa Y, Lopes TJS, Dutta J, Khan Z, Kriti D, van Bakel H, Yamada S, Watanabe T, Imai M, Kawaoka Y.

Nat Microbiol. 2019 Apr 29. doi: 10.1038/s41564-019-0433-6. [Epub ahead of print]

PMID:
31036910
12.

Comparison between stereotactic radiosurgery and whole-brain radiotherapy for 10-20 brain metastases from non-small cell lung cancer.

Mizuno T, Takada K, Hasegawa T, Yoshida T, Murotani K, Kobayashi H, Sakurai T, Yamashita Y, Akazawa N, Kojima E.

Mol Clin Oncol. 2019 May;10(5):560-566. doi: 10.3892/mco.2019.1830. Epub 2019 Mar 20.

13.

Combination of eribulin plus AKT inhibitor evokes synergistic cytotoxicity in soft tissue sarcoma cells.

Hayasaka N, Takada K, Nakamura H, Arihara Y, Kawano Y, Osuga T, Murase K, Kikuchi S, Iyama S, Emori M, Sugita S, Hasegawa T, Takasawa A, Miyanishi K, Kobune M, Kato J.

Sci Rep. 2019 Apr 8;9(1):5759. doi: 10.1038/s41598-019-42300-z.

14.

Fluorinated and Bio-Based Polyamides with High Transparencies and Low Yellowness Index.

Takada K, Mae Y, Kaneko T.

Polymers (Basel). 2018 Nov 27;10(12). pii: E1311. doi: 10.3390/polym10121311.

15.

Association of Low Body Mass Index With Poor Clinical Outcomes After Resection of Non-small Cell Lung Cancer.

Takada K, Shimokawa M, Akamine T, Ono Y, Haro A, Osoegawa A, Tagawa T, Mori M.

Anticancer Res. 2019 Apr;39(4):1987-1996. doi: 10.21873/anticanres.13309.

PMID:
30952742
16.

Spindle cell rhabdomyosarcoma in a lumbar vertebra with FUS-TFCP2 fusion.

Tagami Y, Sugita S, Kubo T, Iesato N, Emori M, Takada K, Tsujiwaki M, Segawa K, Sugawara T, Kikuchi T, Hasegawa T.

Pathol Res Pract. 2019 Mar 27:152399. doi: 10.1016/j.prp.2019.03.027. [Epub ahead of print]

PMID:
30948206
17.

Quantifying faces three-dimensionally in orthodontic practice.

Tanikawa C, Akcam MO, Takada K.

J Craniomaxillofac Surg. 2019 Jun;47(6):867-875. doi: 10.1016/j.jcms.2019.02.012. Epub 2019 Mar 6.

PMID:
30926238
18.

Gastrointestinal Stromal Tumor in a Patient with Neurofibromatosis Type 1 that Was Successfully Treated with Regorafenib.

Fujimi A, Nagamachi Y, Yamauchi N, Tamura F, Kimura T, Miyajima N, Inomata H, Nishisato T, Yoshida M, Takada K, Kobayashi K, Kato J.

Intern Med. 2019 Mar 28. doi: 10.2169/internalmedicine.2321-18. [Epub ahead of print]

19.

High Incidence of Diabetes in People with Extremely High High-Density Lipoprotein Cholesterol: Results of the Kanagawa Investigation of Total Checkup Data from the National Database-1 (KITCHEN-1).

Nakajima K, Higuchi R, Iwane T, Shibata M, Takada K, Sugiyama M, Matsuda M, Nakamura T.

J Clin Med. 2019 Mar 19;8(3). pii: E381. doi: 10.3390/jcm8030381.

20.

miR-7977 inhibits the Hippo-YAP signaling pathway in bone marrow mesenchymal stromal cells.

Yoshida M, Horiguchi H, Kikuchi S, Iyama S, Ikeda H, Goto A, Kawano Y, Murase K, Takada K, Miyanishi K, Kato J, Kobune M.

PLoS One. 2019 Mar 5;14(3):e0213220. doi: 10.1371/journal.pone.0213220. eCollection 2019.

21.

Alveolar soft part sarcoma metastatic to the breast: a case report.

Asano Y, Kashiwagi S, Takada K, Tokimasa S, Takashima T, Ohsawa M, Hirakawa K, Ohira M.

BMC Surg. 2019 Mar 4;19(1):30. doi: 10.1186/s12893-019-0494-8.

22.

Pembrolizumab-induced Autoimmune Hemolytic Anemia and Hemophagocytic Lymphohistiocytosis in Non-small Cell Lung Cancer.

Okawa S, Kayatani H, Fujiwara K, Ozeki T, Takada K, Iwamoto Y, Minami D, Sato K, Shibayama T.

Intern Med. 2019;58(5):699-702. doi: 10.2169/internalmedicine.1001-18. Epub 2019 Mar 1.

23.

A Clinicopathological and Prognostic Analysis of PD-L2 Expression in Surgically Resected Primary Lung Squamous Cell Carcinoma.

Matsubara T, Takada K, Azuma K, Takamori S, Toyokawa G, Haro A, Osoegawa A, Tagawa T, Kawahara A, Akiba J, Okamoto I, Nakanishi Y, Oda Y, Hoshino T, Maehara Y.

Ann Surg Oncol. 2019 Jun;26(6):1925-1933. doi: 10.1245/s10434-019-07257-3. Epub 2019 Feb 27.

PMID:
30815803
24.

Prognostic Impact of Programmed Death-Ligand 2 Expression in Primary Lung Adenocarcinoma Patients.

Takamori S, Takada K, Azuma K, Jogo T, Shimokawa M, Toyokawa G, Hirai F, Tagawa T, Kawahara A, Akiba J, Okamoto I, Nakanishi Y, Oda Y, Hoshino T, Maehara Y.

Ann Surg Oncol. 2019 Jun;26(6):1916-1924. doi: 10.1245/s10434-019-07231-z. Epub 2019 Feb 27.

PMID:
30815801
25.

Kanagawa Investigation of the Total Check-up Data from the National database (KITCHEN): protocol for data-driven population-based repeated cross-sectional and 6-year cohort studies.

Nakajima K, Iwane T, Higuchi R, Shibata M, Takada K, Uda J, Anan M, Sugiyama M, Nakamura T.

BMJ Open. 2019 Feb 21;9(2):e023323. doi: 10.1136/bmjopen-2018-023323.

26.

Prognostic value of quality-of-life scores in patients with breast cancer undergoing preoperative chemotherapy.

Takada K, Kashiwagi S, Fukui Y, Goto W, Asano Y, Morisaki T, Takashima T, Hirakawa K, Ohira M.

BJS Open. 2018 Nov 26;3(1):38-47. doi: 10.1002/bjs5.50108. eCollection 2019 Feb.

27.

Genetic polymorphism of 27 X-chromosomal short tandem repeats in an Egyptian population.

Fukuta M, Gaballah M, Takada K, Miyazaki H, Kato H, Aoki Y, Hamed SS, ElMorsi DAA, ElDakroory SA.

Leg Med (Tokyo). 2019 Mar;37:64-66. doi: 10.1016/j.legalmed.2019.01.009. Epub 2019 Jan 24.

PMID:
30711876
28.

[A Case of Breast Neuroendocrine Carcinoma].

Goto W, Kashiwagi S, Takada K, Asano Y, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2432-2434. Japanese.

PMID:
30692488
29.

[A Case of a Malignant Phyllodes Tumor That Was Difficult to Distinguish from Stromal Sarcoma].

Goto W, Kashiwagi S, Takada K, Asano Y, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2429-2431. Japanese.

PMID:
30692487
30.

[A Case of Multiple Lung Metastases from Breast Cancer Successfully Treated with Endocrine Therapy].

Goto W, Kashiwagi S, Takada K, Asano Y, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2426-2428. Japanese.

PMID:
30692486
31.

[A Case of Male Breast Cancer Suspected of Breast Metastasis from Pancreatic Cancer].

Takada K, Kashiwagi S, Amano R, Goto W, Asano Y, Ohira G, Yamazoe S, Kimura K, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2018 Dec;45(13):1857-1859. Japanese.

PMID:
30692377
32.

[A Case of Invasive Ductal Carcinoma with Paget's Disease of the Breast].

Asano Y, Kashiwagi S, Goto W, Takada K, Ishihara S, Tauchi Y, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2018 Dec;45(13):1842-1844. Japanese.

PMID:
30692372
33.

Trastuzumab-Based Combination Chemotherapy in Patients with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Carcinoma ex Pleomorphic Adenoma.

Arihara Y, Murase K, Takada K, Hayasaka N, Miura S, Miyanishi K, Kobune M, Kurose M, Akiyama Y, Sugita S, Kato J.

Case Rep Oncol. 2018 Dec 11;11(3):835-841. doi: 10.1159/000495344. eCollection 2018 Sep-Dec.

34.

Factors That Affect Oral Care Outcomes for Institutionalized Elderly.

Nomura Y, Takei N, Ishii T, Takada K, Amitani Y, Koganezawa H, Fukuhara S, Asai K, Uozumi R, Bessho K.

Int J Dent. 2018 Dec 10;2018:2478408. doi: 10.1155/2018/2478408. eCollection 2018.

35.

Co-expression of IDO1 and PD-L1 in lung squamous cell carcinoma: Potential targets of novel combination therapy.

Takada K, Kohashi K, Shimokawa M, Haro A, Osoegawa A, Tagawa T, Seto T, Oda Y, Maehara Y.

Lung Cancer. 2019 Feb;128:26-32. doi: 10.1016/j.lungcan.2018.12.008. Epub 2018 Dec 10.

PMID:
30642449
36.

SurE is a trans-acting thioesterase cyclizing two distinct non-ribosomal peptides.

Matsuda K, Kobayashi M, Kuranaga T, Takada K, Ikeda H, Matsunaga S, Wakimoto T.

Org Biomol Chem. 2019 Jan 31;17(5):1058-1061. doi: 10.1039/c8ob02867b.

PMID:
30637418
37.

Metastasis of lower gingival squamous cell carcinoma to buccinator lymph node: case report and review of the literature.

Takada K, Kuroshima T, Shimamoto H, Ohsako T, Kayamori K, Ikeda T, Harada H.

World J Surg Oncol. 2019 Jan 10;17(1):13. doi: 10.1186/s12957-019-1559-y. Review.

38.

Success of Crizotinib Combined with Whole-Brain Radiotherapy for Brain Metastases in a Patient with Anaplastic Lymphoma Kinase Rearrangement-Positive Non-Small-Cell Lung Cancer.

Okawa S, Shibayama T, Shimonishi A, Nishimura J, Ozeki T, Takada K, Kayatani H, Minami D, Sato K, Fujiwara K, Yonei T, Sato T, Suno M.

Case Rep Oncol. 2018 Nov 29;11(3):777-783. doi: 10.1159/000492150. eCollection 2018 Sep-Dec.

39.

Clinical verification of the relationship between smoking and the immune microenvironment of breast cancer.

Takada K, Kashiwagi S, Asano Y, Goto W, Takahashi K, Fujita H, Takashima T, Tomita S, Hirakawa K, Ohira M.

J Transl Med. 2019 Jan 7;17(1):13. doi: 10.1186/s12967-019-1773-y.

40.

[An elderly case of squamous cell lung cancer treated continuously with pembrolizumab without any decline in the life function].

Sazuka M, Murano Y, Takada K, Nonaka K, Yamada H, Yamamoto H.

Nihon Ronen Igakkai Zasshi. 2018;55(4):679-685. doi: 10.3143/geriatrics.55.679. Japanese.

41.

PLPBP mutations cause variable phenotypes of developmental and epileptic encephalopathy.

Shiraku H, Nakashima M, Takeshita S, Khoo CS, Haniffa M, Ch'ng GS, Takada K, Nakajima K, Ohta M, Okanishi T, Kanai S, Fujimoto A, Saitsu H, Matsumoto N, Kato M.

Epilepsia Open. 2018 Nov 1;3(4):495-502. doi: 10.1002/epi4.12272. eCollection 2018 Dec.

42.

Secondary malignant giant cell tumor of bone with histone H3.3 mutation: A case series.

Emori M, Nagoya S, Sugawara M, Mizushima E, Shimizu J, Murahashi Y, Murase K, Takada K, Sugita S, Takagi M, Hasegawa T, Yamashita T.

J Orthop Sci. 2018 Dec 3. pii: S0949-2658(18)30325-7. doi: 10.1016/j.jos.2018.11.002. [Epub ahead of print] No abstract available.

PMID:
30522923
43.

HMGB1 blockade significantly improves luminal fibrous obliteration in a murine model of bronchiolitis obliterans syndrome.

Takamori S, Shoji F, Okamoto T, Kozuma Y, Matsubara T, Haratake N, Akamine T, Katsura M, Takada K, Toyokawa G, Tagawa T, Maehara Y.

Transpl Immunol. 2019 Apr;53:13-20. doi: 10.1016/j.trim.2018.11.007. Epub 2018 Dec 1.

PMID:
30508580
45.

Halo formations around senile hemangiomas in diffuse plane normolipemic xanthomatosis associated with monoclonal gammopathy.

Hida T, Takahashi H, Takada K, Uhara H.

JAAD Case Rep. 2018 Nov 10;4(10):1034-1036. doi: 10.1016/j.jdcr.2018.08.012. eCollection 2018 Nov. No abstract available.

46.

Possibility of avoiding axillary lymph node dissection by immune microenvironment monitoring in preoperative chemotherapy for breast cancer.

Takada K, Kashiwagi S, Goto W, Asano Y, Takahashi K, Fujita H, Takashima T, Tomita S, Hirakawa K, Ohira M.

J Transl Med. 2018 Nov 19;16(1):318. doi: 10.1186/s12967-018-1692-3.

47.

Predictive value of lymphocyte-to-monocyte ratio in the preoperative setting for progression of patients with breast cancer.

Goto W, Kashiwagi S, Asano Y, Takada K, Takahashi K, Hatano T, Takashima T, Tomita S, Motomura H, Hirakawa K, Ohira M.

BMC Cancer. 2018 Nov 19;18(1):1137. doi: 10.1186/s12885-018-5051-9.

48.

Differences in PD-L1 expression on tumor and immune cells between lung metastases and corresponding primary tumors.

Takamori S, Takada K, Tagawa T, Toyokawa G, Hirai F, Yamashita N, Okamoto T, Oki E, Yoshizumi T, Oda Y, Maehara Y.

Surg Oncol. 2018 Dec;27(4):637-641. doi: 10.1016/j.suronc.2018.08.001. Epub 2018 Aug 11.

PMID:
30449485
49.

Significance of intrinsic breast cancer subtypes on the long-term prognosis after neoadjuvant chemotherapy.

Goto W, Kashiwagi S, Takada K, Asano Y, Takahashi K, Fujita H, Takashima T, Tomita S, Hirakawa K, Ohira M.

J Transl Med. 2018 Nov 9;16(1):307. doi: 10.1186/s12967-018-1679-0.

50.

Six-transmembrane epithelial antigen of the prostate 1 protects against increased oxidative stress via a nuclear erythroid 2-related factor pathway in colorectal cancer.

Nakamura H, Takada K, Arihara Y, Hayasaka N, Murase K, Iyama S, Kobune M, Miyanishi K, Kato J.

Cancer Gene Ther. 2018 Nov 7. doi: 10.1038/s41417-018-0056-8. [Epub ahead of print]

PMID:
30401882

Supplemental Content

Loading ...
Support Center